Home>Clinical Trials>Available Clinical Trials

Available Ovarian Clinical Trials

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).
E-mail: askrpci@roswellpark.org

(GOG 3003) A Randomized, Double-Blind, Placebo-Controlled Phase II Study of VTX-2337 (IND #78,416) in Combination with Pegylated Liposomal Doxorubicin (PLD) in Patients with Recurrent or Persistent Epithelial Ovarian, Fall...
(GOG 212) A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 (IND #70177) Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian,...
A Phase I Clinical Trial of mTOR Inhibition with Sirolimus for Enhancing ALVAC(2)-NY-ESO-1(M)/TRICOM Vaccine Induced Anti-Tumor Immunity in Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Patient Reported Symptoms in Ovarian Cancer (Precision)
(GOG 0262) A Randomized Phase III Trial of Every-3-Weeks Paclitaxel, Versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin With or Without Concurrent and Consolidation Bevacizumab (NSC #704865, IND# 7921) in...
Phase 1-2 Study of an Immunotherapeutic Vaccine, DPX-Survivac with Low Dose Cyclophosphamide in Patients with Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer
(GOG 0271) A Study of the Local and Systemic Effects of Intraperitoneal Chemotherapy in the Treatment of Previously-Untreated, Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma